Making genomics available to all is critical in realizing its potential to save and improve lives. That’s why we are driving down the cost of sequencing, expanding access to advanced technology, and increasing the diversity of genomics data.
2023 progress: 9893 patents issued worldwide at the end of 2023
2023 progress: 352 units of new breakthrough NovaSeq X series shipped
2023 progress: 1.3 billion lives covered for genomics testing
*$200 USD genome on NovaSeq X Series is delivered at list price on 25B flow cell. Data on file.
Genomics has been integrated into clinical practice at a faster rate than almost any innovation in the history of medicine, but inequities still exist. Implementation has been almost entirely restricted to more developed nations, and 78% of people included in genomic studies of disease risk are of European ancestry. To ensure that genomes can be interpreted in the appropriate context of global diversity, we aim to increase the equitable representation of genomic data. This allows for therapies and solutions to be attuned to a broader set of genomes, decreasing this bias in our medicine for the future.
iHope is a philanthropic effort that provides clinical whole-genome sequencing (cWGS) to underserved families around the globe. It brings together a wide range of organizations aiming to shorten the diagnostic journey and inspire hope.
Efforts include the iHope program under the auspices of the nonprofit Genetic Alliance and iHope China with March of Dimes.
Through our partnership with Genetic Alliance, iHope Genetic Health aims to provide clinical whole-genome sequencing (WGS) access to tens of thousands of families across the globe impacted by genetic disease. At least half of iHope Genetic Health's efforts focus on areas of the world in need outside the US, with more than one-third of Illumina support dedicated to patients in Africa.
Through direct programming, nonprofit partners, and employee engagement, we aim to enable educators to be advocates of genomics and inspire learners of all ages to envision themselves as future leaders in STEM.
To date, our Illumina for Startups initiatives have raised over $1.1 billion in collective venture capital funding.